EUVIMEDEUVIMED entdecken
Open Access

CD45⁺ hybrid circulating cells may reflect tumor-immune interactions and serve as transcriptomic indicators of metastatic potential in prostate cancer

Baek Gil Kim, Yeonsue Jang, Min Gyu Kim, Dongwook Song, Jungchan Jung, Jihee Jung, Ayoung Yoo, Jongsoo Lee, Nam Hoon Cho, Hyeong Jung Woo, Woon-Hae Kim, Hyun Young Shin und 3 weitere

Theranostics · 2026

DOI: 10.7150/thno.122226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Baek Gil Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Ko…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Leukocyte Common Antigens, Neoplastic Cells, Circulating, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Circulating hybrid cells expressing both epithelial and immune markers have emerged as indicators of dynamic tumor-immune interactions. This study aimed to characterize circulating hybrid cells co-expressing KRT18 (pan-cytokeratin) and PTPRC (CD45), termed KP_Pos, in metastatic prostate cancer (mPCa), and to assess their molecular features, tumor microenvironmental (TME) origins, and clinical relevance.

Methods

Imaging mass cytometry (IMC) was used to examine spatial relationships between CK⁺ tumor and CD45⁺ immune cells in metastatic prostate tissues. Single-cell RNA sequencing (scRNA-seq) datasets from mPCa were analyzed to identify KP_Pos cells and characterize their transcriptional heterogeneity across epithelial and immune lineages. Differentially expressed genes (DEGs) between KP_Pos and other cells were used to generate predictive gene signatures. Random forest (RF) and extreme gradient boosting (XGB) models were applied to evaluate metastatic classification performance, and high-performing signatures were validated in bulk RNA-seq datasets and correlated with clinical parameters.

Results

IMC revealed frequent spatial proximity between tumor and immune compartments, supporting a TME-derived hybrid phenotype. KP_Pos cells were detected across multiple immune and epithelial clusters, showing heterogeneity and enrichment of immune response and epithelial-mesenchymal transition (EMT)-related genes. Machine learning-based classifiers using KP_Pos-derived DEGs achieved high predictive accuracy (AUC ≥ 0.7) for metastasis, and selected combinations further improved performance in internal validation sets. Signature scores significantly correlated with PSA and Gleason grade, and CD45⁺ hybrid circulating cells were more abundant in patients with advanced disease burden.

Conclusions

CD45⁺ KRT18⁺ hybrid circulating cells (KP_Pos) represent biologically distinct populations shaped by tumor-immune interactions within the TME. Their transcriptomic features and derived gene signatures may serve as biomarkers of metastatic potential and indicators of disease progression in prostate cancer. However, their causal role in metastasis and impact on survival remain to be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLeukocyte Common AntigensNeoplastic Cells, CirculatingTranscriptomeHumansMaleTumor MicroenvironmentBiomarkers, TumorNeoplasm MetastasisSingle-Cell AnalysisGene Expression Profiling

Stichwörter der Autor:innen

CD45⁺ KRT18⁺ hybrid cellsCirculating hybrid cellsMetastasis predictionProstate cancerSingle-cell RNA sequencingTumor-immune interaction

Substanzen

Leukocyte Common AntigensPTPRC protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Center for Urologic Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 10408, Republic of Korea.
  • Department of Pathology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology (DGIST), 333 Techno Jungang-daero, Hyeonpung-eup, Dalseong-gun, Daegu 42988, Republic of Korea.
  • CTCELLS Inc., 216, Gaepo-ro, Gangnam-gu, Seoul 06307, Republic of Korea.

Zitieren

APA

Kim, B. G., Jang, Y., Kim, M. G., Song, D., Jung, J., Jung, J., Yoo, A., Lee, J., Cho, N. H., Woo, H. J., Kim, W. H., Shin, H. Y., Kim, M. S., Han, H. H., & Joung, J. Y. (2026). CD45⁺ hybrid circulating cells may reflect tumor-immune interactions and serve as transcriptomic indicators of metastatic potential in prostate cancer. Theranostics. https://doi.org/10.7150/thno.122226

Vancouver

Kim BG, Jang Y, Kim MG, Song D, Jung J, Jung J, et al. CD45⁺ hybrid circulating cells may reflect tumor-immune interactions and serve as transcriptomic indicators of metastatic potential in prostate cancer. Theranostics. 2026. doi:10.7150/thno.122226

BibTeX
@article{Kim2026,
  author = {Kim, Baek Gil and Jang, Yeonsue and Kim, Min Gyu and Song, Dongwook and Jung, Jungchan and Jung, Jihee and Yoo, Ayoung and Lee, Jongsoo and Cho, Nam Hoon and Woo, Hyeong Jung and Kim, Woon-Hae and Shin, Hyun Young and Kim, Minseok S and Han, Hyun Ho and Joung, Jae Young},
  title = {CD45⁺ hybrid circulating cells may reflect tumor-immune interactions and serve as transcriptomic indicators of metastatic potential in prostate cancer},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.122226}
}
Kostenlos starten →